Incidence of Cancer

Back to Incidence of Cancer
Elekta to Showcase Comprehensive, Integrated Solution Portfolio to Equip Radiation Oncology Departments at ESTRO 2012

BARCELONA, May 7, 2012 /PRNewswire/ -- ESTRO Booth #200 -- At the 2012 European Society for Therapeutic Radiology and Oncology (ESTRO) exhibition, 9-13 May at the Centro de Convenciones Internacional de Barcelona, Elekta will demonstrate the richness of its spectrum of radiation oncology solutions with the Elekta Cancer Care Clinic. The clinic is the patient's or doctor's view of the comprehensive, well-integrated radiotherapy department, showcasing Elekta's entire portfolio.

The Elekta Cancer Care Clinic will feature a floor plan that includes replicas of a reception area, pre-treatment and simulation rooms, doctor's office, treatment planning and physics rooms, and a treatment delivery suite. Within each area will be arrayed Elekta solutions, encompassing Leksell Gamma Knife® Perfexion(TM) stereotactic radiosurgery, linac-based radiotherapy, brachytherapy, MOSAIQ® Oncology Information System, treatment planning solutions and much more. The primary theme for the 2012 ESTRO exhibit is "Experience the Elekta Difference."

"Our secondary theme is 'With You All the Way,' which conveys to our customers and prospective customers that Elekta is their single partner who can provide them with complete, integrated solutions for their clinical practice," says Olof Sanden, Elekta's Executive Vice President, Europe and AFLAME. "This theme also communicates that we can offer customers tailored and personalized solutions regardless of whether they're just starting a practice or need to expand."

New Agility MLC and brachytherapy solutions
To be prominently highlighted in the Elekta exhibit will be Agility(TM)*, Elekta's revolutionary new 160-leaf MLC, featuring leaf speeds of up to 6.5 cm per second -- twice as fast as the leaf speeds of other MLCs commonly used in the industry. The Agility high resolution MLC will enable clinicians to further exploit the benefits of advanced techniques such as SRT and VMAT. Agility also features an extremely low leakage design -- considerably lower leakage than other commercial MLCs. Elekta strongly believes patients and clinics will benefit from the speed and reliability of this new MLC design.

In March 2012, Elekta announced it had achieved CE Marking for Agility, enabling medical centers across Europe and other regions to adopt the technology.

Brachytherapy solutions also will be highly visible in the Elekta exhibit during ESTRO 31, as well as Booth #50 at The World Congress of Brachytherapy, convening 10-12 May. In September 2011, Elekta completed the acquisition of Nucletron, the world leader in brachytherapy. Now, in addition to providing proven solutions that employ external beam radiation, Elekta also offers a world class therapy that treats cancer from the "inside out."

Remote Services
Also to be featured at the ESTRO 2012 is Elekta Remote Services, which uses advanced technology to actively monitor customer systems. The results are reduced downtime and fewer interruptions in the practice schedule. Offering proactive rather than reactive services means systems issues can be predicted before they happen, the correct part can be identified and ordered, and a convenient time for service can be arranged all before the fault impacts the customer. Elekta Remote Services is available for all Elekta systems.

Other meeting highlights
Elekta will host a lunch symposium titled One Elekta: Your Clinical Partner on Thursday, 10 May from 13:00-14:20 in room 116. An interactive forum, the symposium will feature presentations by notable experts in the field of radiation oncology:

    --  Prof. F. Guedea, Instituto Catalan de Oncologia, Barcelona, Spain:
        Targeting Radiation Therapy to Patients: The Role of Brachytherapy
    --  June Dean DCR(T), MSc Medical Physics, Oncology Center, Addenbrooke's
        Hospital, Cambridge, U.K.: Integrating MOSAIQ into a Multi-Vendor
        Department
    --  Dr. Vivian Cosgrove, St. James's Institute of Oncology, Leeds, U.K.:
        Commissioning of the Elekta Agility for Clinical Use

To learn more about Elekta's innovations at ESTRO, visit www.elekta.com/experience.

*Agility is CE Marked, but not licensed for sale in all markets.

For further information, please contact:
Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37, email: stina.thorman@elekta.com
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

SOURCE Elekta

Copyright (2014) PR Newswire. All Rights Reserved.
Back to Incidence of Cancer
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki